Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Transplantation: early-phase trial registry
6 of 13 indexed Lung Transplantation trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,315 of 28,707 conditions by registered trial count.
13 US clinical trials · 6 currently recruiting · #1,315 of 28,707 conditions by registered trial count
Lung Transplantation: 13 US clinical trials tracked, 6 recruiting.
Lung Transplantation is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of Pittsburgh, running 2 of these trials.
Enrollment posture brief
Registry condition lung-transplantation
OPEN 6 | RECR 46% | LATE 1 | EARLY 3 | RANK #1315 | SPON 2
Volume-matched condition peers
Nearest open-share peer: B-cell Lymphoma (46% recruiting · 39 trials)
Lung Transplantation lists 6 open slots (46% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lung Transplantation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lung Transplantation recruits in line with its size-band peers.
6 of 13 indexed trials (46.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Lung Transplantation research.
University of Pittsburgh accounts for 2 of 13 trials (15.4%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Lung Transplantation enrolment sits around 90 participants.
Median target enrolment is 90 among the 13 trials that report a genuine target (sentinel values excluded). 7 of those (53.8%) plan for fewer than 100 participants.
-
Lung Transplantation splits between interventional and observational designs.
7 interventional and 6 observational studies make up this index (53.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
13 total, page 1 of 1
Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation
University of Pennsylvania
NCT00457847
Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
University of Pennsylvania
NCT00552357
Trifecta-Lung cfDNA-MMDx Study
University of Alberta
NCT05837663
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
University of California, San Francisco
NCT06853223
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Steven Hays, MD
NCT06018766
Transplanting Lungs From Uncontrolled Donation After Circulatory Death
NYU Langone Health
NCT06327945
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
TransMedics
NCT03639025
Inspiratory Muscle Training Immediately After Lung Transplantation
Ohio State University
NCT05309551
Rapid Detection of Airway Pathogens for Lung Transplantation
University of California, San Francisco
NCT03933878
Lung Transplant G0 (LTGO): Improving Self-Management of Exercise After Lung Transplantation
University of Pittsburgh
NCT03728257
Lung Transplant Specimen Repository and Data Registry Protocol
Karen Wood
NCT00816257
Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study
University of Pittsburgh
NCT00177710
Intravenous Immunoglobulin (IVIG) in Lung Transplantation
Columbia University
NCT00115778
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Lung Transplantation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lung Transplantation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lung Transplantation page
13 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Lung Transplantation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Pittsburgh sponsors the most Lung Transplantation trials on record, review their full trial history before evaluating a specific study. See University of Pittsburgh's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lung Transplantation condition card totals 13 registered trials; most-linked intervention Placebo; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.